
ISSN: 2643-6760
Potru S1, Joseph A2 and Rajendram R3,4
Received: February 06, 2020; Published: February 18, 2020
Corresponding author: Rajkumar Rajendram AKC BSc (Hons) MBBS (Dist) MRCP (UK) EDIC FRCP Edin FRCP Lond, Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia
DOI: 10.32474/SCSOAJ.2020.04.000190
Benzodiazepines are characteristically anxiolytic, amnestic, and sedative. However, paradoxical reactions may cause agitation or aggression. We report a case in which a postoperative paradoxical reaction to midazolam was successfully managed with flumazenil (a benzodiazepine-receptor antagonist). Whilst the aetiology of benzodiazepine-induced hyperactivity remains unclear, this report demonstrates that even small amounts of flumazenil is an effective treatment. Despite the risks associated with the use of flumazemil we recommend its use for both diagnostic and therapeutic purposes.
Keywords: Midazolam, Benzodiazipine, Flumazenil
Benzodiazepines are characteristically anxiolytic, amnestic, and sedative. However, paradoxical reactions may result in restlessness, agitation, or aggression. This case report describes successful management of a postoperative paradoxical reaction to midazolam with the benzodiazepine-receptor antagonist flumazenil.
68-year-old Caucasian male with prostate cancer presented
for elective robot-assisted laparoscopic prostatectomy. He also
had osteoarthritis, hypertension, hypercholesterolemia, obesity,
coronary artery disease (post coronary artery bypass graft)
and obstructive sleep apnoea (not requiring CPAP). His regular
medications included aspirin, atorvastatin, finasteride, losartan,
metoprolol, mometasone furoate, nitroglycerin, terazosin, and
meloxicam. He denied previous adverse drug reactions and had not
had any previous complications with general anaesthesia.
He was premedicated with midazolam (2 mg i.v.) and, notably,
was relaxed and drowsy thereafter. The patient was induced
without incident using fentanyl 200 mcg, propofol 250 mg and
vecuronium 10 mg. Anaesthesia was maintained with isoflurane,
remifentanil infusion and intermittent boluses of morphine (total
10 mg). Dexamethasone and diphenhydramine were administered
for prophylaxis against postoperative nausea and vomiting. The
prostatectomy was extremely difficult and was aborted after two
hours. Residual neuromuscular blockade was reversed, isoflurane
was stopped and the patient was extubated uneventfully.
Prior to transfer to the post-anaesthesia care unit (PACU), the
patient became agitated and aggressive. He insisted on using the
restroom to urinate despite having a urinary catheter in situ. He
pulled at the oxygen facemask and required manual restraint to
prevent self-harm from falling out of bed. After administration of 1
mg of midazolam the agitation increased. He struggled against the
restraints and continued to try to get out of bed, despite reassurance
that he had a catheter in his bladder. His vital signs remained
stable throughout this period. Ten minutes later another 1 mg of
midazolam was given and he appeared to settle, so transfer to the
PACU was initiated. En route he became more restless and struggled
against his physical restraints; so, another 1 mg of midazolam was given. On arrival in the PACU, the patient’s vital signs were all stable
(BP 147/83 mmHg, HR 75 beats per minute, SaO2 96%, RR 14
breaths per minute, T 36.4 oC) and there was no focal neurological
deficit but physical restraint was still required. Despite a further 1
mg of midazolam the patient continued to struggle.
Ultimately, flumazenil 0.5mg was given in divided doses to
reverse the effects of midazolam. Within three minutes the patient
calmed, stopped struggling, answered all questions appropriately
and asked for removal of the restraints. He subsequently denied
having any recollection of the preceding events.
The aetiology and mechanism of benzodiazepine-induced paradoxical hyperactivity have yet to be elucidated, although a central cholinergic mechanism has been suggested [1]. This report and others [1] demonstrate even small amounts of flumazenil can be effective in treating this. Despite the risks associated with the use of flumazemil we recommend its use for both diagnostic and therapeutic purposes.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...
The annual scholar awards from Lupine Publishers honor a selected number read more...